Page 178 - Vitamin D and Cancer
P. 178
7 Induction of Differentiation in Cancer Cells by Vitamin D 165
24. Wang X, Patel R, Studzinski GP (2008) hKSR-2, a vitamin D-regulated gene, inhibits
apoptosis in arabinocytosine-treated HL60 leukemia cells. Mol Cancer Ther 7:2798–2806
25. Helander HF (1975) Enzyme patterns and protein absorption in rat colon during develop-
ment. Acta Anat (Basel) 91:330–349
26. Ono K (1976) Alkaline phosphatase activity of the large intestinal principal cells in postnatal
developing rats. Acta Histochem 57:312–319
27. Chen A, Davis BH, Bissonnette M, Scaglione-Sewell B, Brasitus TA (1999)
1,25-Dihydroxyvitamin D3 stimulates activator protein-1-dependent CaCo-2 cell differentia-
tion. J Biol Chem 274:35505–35513
28. Marvin-Guy LF, Duncan P, Wagniere S, Antille N, Porta N, Affolter M, Kussmann M (2008)
Rapid identification of differentiation markers from whole epithelial cells by matrix-assisted
laser desorption/ionisation time-of-flight mass spectrometry and statistical analysis. Rapid
Commun Mass Spectrom 22:1099–1108
29. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla
M, Cano A, de Herreros AG, Lafarga M, Munoz A (2001) Vitamin D3 promotes the differ-
entiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-
catenin signaling. J Cell Biol 154:369–387
30. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED (1989) Serum
25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2:1176–1178
31. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC (2006)
Prospective study of predictors of vitamin D status and cancer incidence and mortality in
men. J Natl Cancer Inst 98:451–459
32. Tong WM, Hofer H, Ellinger A, Peterlik M, Cross HS (1999) Mechanism of antimitogenic
action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal
growth factor-stimulated cell growth. Oncol Res 11:77–84
33. Belleli A, Shany S, Levy J, Guberman R, Lamprecht SA (1992) A protective role of 1,
25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis. Carcinogenesis
13:2293–2298
34. Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR (1993) 1,
25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differen-
tiation and growth inhibition. Cancer Res 53:3712–3718
35. Vandewalle B, Adenis A, Hornez L, Revillion F, Lefebvre J (1994) 1, 25-dihydroxyvitamin
D3 receptors in normal and malignant human colorectal tissues. Cancer Lett 86:67–73
36. Sheinin Y, Kaserer K, Wrba F, Wenzl E, Kriwanek S, Peterlik M, Cross HS (2000) In situ
mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal
and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor
expression. Virchows Arch 437:501–507
37. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E, Peterlik M (2001)
25-Hydroxyvitamin D3–1alpha-hydroxylase and vitamin D receptor gene expression in
human colonic mucosa is elevated during early cancerogenesis. Steroids 66:287–292
38. Qi X, Pramanik R, Wang J, Schultz RM, Maitra RK, Han J, DeLuca HF, Chen G (2002) The
p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and
sensitize human breast cancer cells to vitamin D3-induced growth inhibition. J Biol Chem
277:25884–25892
39. Wiese RJ, Uhland-Smith A, Ross TK, Prahl JM, DeLuca HF (1992) Up-regulation of the
vitamin D receptor in response to 1, 25-dihydroxyvitamin D3 results from ligand-induced
stabilization. J Biol Chem 267:20082–20086
40. Alrefai WA, Scaglione-Sewell B, Tyagi S, Wartman L, Brasitus TA, Ramaswamy K, Dudeja
+
+
PK (2001) Differential regulation of the expression of Na /H exchanger isoform NHE3 by
PKC-alpha in CaCo-2 cells. Am J Physiol Cell Physiol 281:C1551–C1558
41. Wali RK, Baum CL, Sitrin MD, Brasitus TA (1990) 1, 25(OH) vitamin D3 stimulates mem-
2
brane phosphoinositide turnover, activates protein kinase C, and increases cytosolic calcium
in rat colonic epithelium. J Clin Invest 85:1296–1303